Abstract
Systemic sclerosis or scleroderma (SSc) is characterized by immunologic abnormalities, microvascular alterations, and excessive collagen production, leading to fibrosis of skin and internal organs (lungs, heart, gastrointestinal tract).
Hands are prominent targets of SSc and may be involved at different levels. Frequent signs and symptoms of the disease, such as skin and microcirculatory impairment as well as musculoskeletal involvement (of joints, tendons, and muscles), usually begin from the hands. Hand involvement evolves throughout all the course of the disease and leads to important disability in SSc.
This chapter analyzes the involvement of the hands in SSc, focusing on the causes and the kind of functional disturbances; relation between hand impairment and other clinical parameters; hand function in different stages of the disease; and tools to assess damage and function of the hand.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wigley FM. Systemic sclerosis: clinical features. In: Klippel JH, Dieppe PA, editors. Rheumatology. Philadelphia: Mosby; 1998. p. 7.9.1.
Poole JL. Grasp pattern variations seen in the scleroderma hand. Am J Occup Ther. 1994;48(1):46–54.
Maddali-Bongi S, Del Rosso A, Passalacqua M, Miccio S, Matucci-Cerinic M. Manual lymph drainage improves upper limb oedema and hand function in patients with systemic sclerosis (SSc) in oedematous phase. Arthritis Care Res. 2011;63:1134–41.
Khanna PP, Furst DE, Clements PJ, et al. Tendon friction rubs in early diffuse systemic sclerosis: prevalence, characteristics and longitudinal changes in a randomized controlled trial. Rheumatology (Oxford). 2010;49:955–9.
Entin MA, Wilkinson RD. Scleroderma hand: a reappraisal. Orthop Clin North Am. 1973;4:1031–8.
Palmer DC, Hale GM, Grennan DM, et al. Bowed fingers: a helpful sign in the early diagnosis of systemic sclerosis. J Rheumatol. 1981;8:266–72.
Bandinelli F, Kaloudi O, Candelieri A, et al. Early detection of median nerve syndrome at the carpal tunnel with high-resolution 18 MHz ultrasonography in systemic sclerosis patients. Clin Exp Rheumatol. 2010;28(5 Suppl 62):S15–8.
Czirják L, Foeldvari I, Müller-Ladner U. Skin involvement in systemic sclerosis. Rheumatology (Oxford). 2008;47 Suppl 5:v44–5.
Clements PJ, Lachenbrunch PA, Seibold JR, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol. 1993;20:1892–6.
Verrechia F, Laboureau J, Verola O, et al. Skin involvement in scleroderma—where histological and clinical scores meet. Rheumatology. 2007;46:833–41.
Kissin EY, Schiller AM, Gelbard RB, et al. Durometry for the assessment of skin disease in systemic sclerosis. Arthritis Rheum. 2006;55:603–9.
Merkel PA, Silliman NP, Denton CP, et al. for the CAT-192 Research Group and the Scleroderma Clinical Trials Consortium. Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial. Arthritis Rheum. 2008;59:699–705.
Kaloudi O, Bandinelli F, Filippucci E, et al. High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis. Ann Rheum Dis. 2010;69:1140–3.
Iagnocco A, Kaloudi O, Perella C, et al. Ultrasound elastography assessment of skin involvement in systemic sclerosis: lights and shadows. J Rheumatol. 2010;37:1688–91.
Bonél H, Messer G, Seemann M, et al. MRI of fingers in systemic scleroderma. Initial results with contrast-enhanced studies using a dedicated MRI system. Radiologe. 1997;37:794–801.
Resnick D. Scleroderma (progressive systemic sclerosis). In: Resnick D, editor. Diagnosis of bone and joint disorders. 3rd ed. Philadelphia: Saunders; 1995. p. 1191–217.
Avouac J, Guerini H, Wipff J, et al. Radiological hand involvement in systemic sclerosis. Ann Rheum Dis. 2006;65:1088–92.
Tuffanelli DL, Winkelmann RK. Systemic scleroderma: a clinical study of 727 cases. Arch Dermatol. 1961;84:359–71.
Baron M, Lee P, Keistone EC. The articular manifestations of progressive systemic sclerosis (scleroderma). Ann Rheum Dis. 1982;41:147–52.
Erre GL, Marongiu A, Fenu P, et al. The “sclerodermic hand”: a radiological and clinical study. Joint Bone Spine. 2008;75:426–31.
Blocka K, Bassett LW, Furst DE, et al. The arthropathy of advanced of progressive systemic sclerosis. Arthritis Rheum. 1981;24:874–84.
Ashida R, Ihn H, Mimura Y, et al. Clinical features of scleroderma patients with contracture of phalanges. Clin Rheumatol. 2007;26:1275–7.
Brower LM, Poole JL. Reliability and validity of the Duruöz hand index in person with systemic sclerosis (scleroderma). Arthritis Rheum. 2004;51:805–9.
Maddali-Bongi S, Del Rosso A, Galluccio F, et al. Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis. Clin Rheumatol. 2009;28:1167–73.
Sandqvist G, Hesselstrand R, Eberhardt K. A longitudinal follow-up of hand involvement and activities of daily living in early systemic sclerosis. Scand J Rheumatol. 2009;38:304–10.
Sandqvist G, Scheja A, Hesselstrand R. Pain, fatigue and hand function closely correlated to work ability and employment status in systemic sclerosis. Rheumatology (Oxford). 2010;49:1739–46.
Misra R, Darton K, Jewkes RF, Black CM, Maini RN. Arthritis in scleroderma. Br J Rheumatol. 1995;34:831–7.
Pope JE. Musculoskeletal involvement in scleroderma. Rheum Dis Clin N Am. 2003;29:391–408.
Ostojic P, Damjanov N. Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis. Clin Rheumatol. 2006;25:453–7.
Tate G, Schumacher HR. Bone and articular involvement on systemic sclerosis (scleroderma). In: Jayson MIV, Black CM, editors. Systemic sclerosis (scleroderma). New York: Wiley; 1988. p. 247–57.
Catoggio LJ, Evison G, Harkness JAL, Maddison PJ. The arthropathy of systemic sclerosis (scleroderma): comparison with mixed connective tissue disease. Clin Exp Rheumatol. 1983;1:101–12.
Zimmermann C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS. The concurrence of rheumatoid arthritis and limited systemic sclerosis. Arthritis Rheum. 1998;41:1938–45.
Boutry N, Hachulla E, Zanetti-Musielak C, et al. Imaging features of musculoskeletal involvement in systemic sclerosis. Eur Radiol. 2007;17:1172–80.
La Montagna G, Sodano A, Capurro V, et al. The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging study. Skeletal Radiol. 2005;34:35–41.
Brun B, Serup J, Hagdrup H. Radiological changes of the hands in systemic sclerosis. Acta Derm Venereol. 1983;63:349–52.
Cuomo G, Zappia M, Abignano G, et al. Ultrasonographic features of the hand and wrist in systemic sclerosis. Rheumatology (Oxford). 2009;48:1414–7.
Chitale S, Ciapetti A, Hodgson R, et al. Magnetic resonance imaging and musculoskeletal ultrasonography detect and characterize covert inflammatory arthropathy in systemic sclerosis patients with arthralgia. Rheumatology (Oxford). 2010;49:2357–61.
Low AH, Lax M, Johnson SR, Lee P. Magnetic resonance imaging of the hand in systemic sclerosis. J Rheumatol. 2009;36:961–4.
Rodnan GP, Medsger TA. The rheumatic manifestation of progressive systemic sclerosis (scleroderma). Clin Orthop Relat Res. 1968;57:81–93.
Jimenez SA, Derk C. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med. 2004;140:37–50.
Steen VD, Medsger TA. The palpable tendon friction rub. Arthritis Rheum. 1997;40:1146–51.
Clements PJ, Furst DE, Campion DS, et al. Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. Arthritis Rheum. 1978;21:62–71.
De Angelis R, Grassi W, Cutolo M. A growing need for capillaroscopy in rheumatology. Arthritis Rheum. 2009;15(61):405–10.
Sunderkötter C, Riemekasten G. Pathophysiology and clinical consequences of Raynaud’s phenomenon related to systemic sclerosis. Rheumatology (Oxford). 2006;45 Suppl 3:iii33–5.
Hasegawa M, Nagai Y, Tamura A, Ishikawa O. Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis. Br J Dermatol. 2006;155:1159–64.
Ferri C, Valentini G, Cozzi F, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine. 2002;81:139–53.
Block JA, Sequeira W. Raynaud’s phenomenon. Lancet. 2001;357:2042–8.
Denton CP, Korn JH. Digital ulceration and critical digital ischaemia in scleroderma. Scleroderma Care Res. 2003;1:12–6.
Wigley FM, Korn JH, Csuka ME, et al. Oral iloprost treatment in patients with Raynaud phenomenon secondary to systemic sclerosis. Arthritis Rheum. 1998;41:670–7.
Pope JE, Bellamy N. Sample size calculations in scleroderma: a rational approach to choosing outcome measurements in scleroderma trials. Clin Invest Med. 1995;18:1–10.
Hachulla E, Clerson P, Launay D, et al. Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study. J Rheumatol. 2007;34:2423–30.
Walker UA, Tyndall A, Czirják L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis. 2007;66:754–63.
Amanzi L, Braschi F, Fiori G, et al. Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology (Oxford). 2010;49:1374–82.
Steen V, Denton CP, Pope JE, Matucci-Cerinic M. Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology (Oxford). 2009;48 Suppl 3:iii19–24.
Mouthon L, Mestre-Stanislas C, Bérezné A, et al. Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis. Ann Rheum Dis. 2010;69:214–7.
Korn JH. Scleroderma: a treatable disease. Cleve Clin J Med. 2003;70:954–68.
Nihtyanova SI, Brough GM, Black CM, Denton CP. Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis. 2008;67:120–3.
Grassi W, De Angelis R. Capillaroscopy: questions and answers. Clin Rheumatol. 2007;26:2009–16.
Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol. 2000;27:155–60.
Murray AK, Moore TL, King TA, Herrick AL. Abnormal microvascular response is localized to the digits in patients with systemic sclerosis. Arthritis Rheum. 2006;54:1952–60.
Murray AK, Moore TL, Manning JB, et al. Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders. Arthritis Rheum. 2009;61:1103–11.
Gunawardena H, Harris ND, Carmichael C, McHugh NJ. Maximum blood flow and microvascular regulatory responses in systemic sclerosis. Rheumatology (Oxford). 2007;46:1079–82.
Kim SH, Kim HO, Jeong YG, et al. The diagnostic accuracy of power Doppler ultrasonography for differentiating secondary from primary Raynaud’s phenomenon in undifferentiated connective tissue disease. Clin Rheumatol. 2008;27:408–11.
Janevski B. Arteries of the hand in patients with scleroderma. Diagn Imaging Clin Med. 1986;55:262–5.
Dabich L, Bookstein JJ, Zweifler A, Zarafonetis CJ. Digital arteries in patients with scleroderma: arteriographic and plethysmographic study. Arch Intern Med. 1972;130:708–14.
Allanore Y, Seror R, Chevrot A, Kahan A, Drapé JL. Hand vascular involvement assessed by magnetic resonance angiography in systemic sclerosis. Arthritis Rheum. 2007;56:2747–54.
Matucci Cerinic M, Generini S, Pignone A, Casale R. The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms. Rheum Dis Clin North Am. 1996;22:879–92.
Lori S, Matucci-Cerinic M, Casale R, et al. Peripheral nervous system involvement in systemic sclerosis: the median nerve as target structure. Clin Exp Rheumatol. 1996;14:601–5.
Casale R, Buonocore M, Matucci-Cerinic M. Systemic sclerosis (scleroderma): an integrated challenge in rehabilitation. Arch Phys Med Rehabil. 1997;78:767–73.
Mondelli M, Romano C, De Stefano R, Cioni R. Nerve conduction velocity study of the upper limb in Raynaud’s phenomenon. Rheumatol Int. 2000;19:165–9.
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–86.
Bassel M, Hudson M, Taillefer SS, et al. Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology (Oxford). 2011;50:762–7.
van Lankveld WG, Vonk MC, Teunissen H, van den Hoogen FH. Appearance self-esteem in systemic sclerosis—subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variables. Rheumatology. 2007;46:8726.
Richards H, Herrick A, Griffin K, Gwilliam P, Fortune D. Psychological adjustment to systemic sclerosis exploring the association of disease factors, functional ability, body related attitudes and fear of negative evaluation. Psychol Health Med. 2004;9:2939.
Sandqvist G, Eklund M, Akesson A, Nordenskiöld U. Daily activities and hand function in women with scleroderma. Scand J Rheumatol. 2004;33:102–7.
Sandqvist G, Scheja A, Eklund M. Working ability in relation to disease severity, everyday occupations and well-being in women with limited systemic sclerosis. Rheumatology (Oxford). 2008;47:1708–11.
Bérezné A, Seror R, Morell-Dubois S, et al. Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res (Hoboken). 2011;63:277–85.
Avouac J, Mogavero G, Guerini H, et al. Predictive factors of hand radiographic lesions in systemic sclerosis: a prospective study. Ann Rheum Dis. 2011;70:630–3.
Medsger TA, Rodnan GP, Moosy J, et al. Skeletal muscle involvement in progressive systemic sclerosis (scleroderma). Arthritis Rheum. 1968;11:554–68.
Follansbee W, Zerbe T, Medsger TA. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. Am Heart J. 1993;125:194–203.
West SG, Killan PJ, Lawless OJ. Association of myositis and myocarditis in progressive systemic sclerosis. Arthritis Rheum. 1981;24:662–7.
Tiev KP, Diot E, Clerson P, et al. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinerAIR-Sclerodermie). J Rheumatol. 2009;36:1470–6.
Sunderkotter C, Herrgott I, Bruckner C, et al. Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors. Br J Dermatol. 2009;160:835–43.
Poole JL, Steen VD. The use of the HAQ to determine physical disability in SSc. Arthritis Care Res. 1991;4:27–31.
Steen VD, Medsger TA. The value of the HAQ and special patient generated scales to demonstrate change in SSc patients over time. Arthritis Rheum. 1997;40:1984–91.
Johnson SR, Hawker GA, Davis AM. The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties. Arthritis Rheum. 2005;53:256–62.
Ruof J, Brühlmann P, Michel BA, Stucki G. Development and validation of a self-administered systemic sclerosis questionnaire (SySQ). Rheumatology (Oxford). 1999;38:535–42.
Ostojić P, Damjanov N. The scleroderma assessment questionnaire (SAQ). A new self-assessment questionnaire for evaluation of disease status in patients with systemic sclerosis. Z Rheumatol. 2006;65:168–75.
Ostojic P, Damjanov N. Indices of the scleroderma assessment questionnaire (SAQ) can be used to demonstrate change in patients with systemic sclerosis over time. Joint Bone Spine. 2008;75:286–90.
Kallen MA, Mayes MD, Kriseman YL, et al. The symptom burden index: development and initial findings from use with patients with systemic sclerosis. J Rheumatol. 2010;37:1692–8.
Duruöz MT, Poiraudeau S, Fermanian J, et al. Development and validation of a rheumatoid Duruöz’s hand index that assesses functional handicap. J Rheumatol. 1996;23:1167–72.
Poiraudeau S, Chevalier X, Conrozier T, et al. Reliability, validity, and sensitivity to change of the Cochin Duruöz’s hand index in hand osteoarthritis. Osteoarthr Cartil. 2001;9:570–7.
Brower LM, Poole JL. Reliability and validity of the Duruöz hand index in persons with systemic sclerosis (scleroderma). Arthritis Rheum. 2004;51:805–9.
Rannou F, Poiraudeau S, Berezne A, et al. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin hand function scale, health assessment questionnaire (HAQ), systemic sclerosis HAQ, and medical outcomes study 36-item short form health survey. Arthritis Rheum. 2007;57:94–102.
Ingegnoli F, Galbiati V, Boracchi P, et al. Reliability and validity of the Italian version of the hand functional disability scale in patients with systemic sclerosis. Clin Rheumatol. 2008;27:743–9.
Backman C, Mackie H. Arthritis hand function test manual. Vancouver: University of British Columbia; 1997.
Poole JL, Gallegos M, O’Linc S. Reliability and validity of the Arthritis Hand Function Test in adults with systemic sclerosis (scleroderma). Arthritis Care Res. 2000;13:69–73.
Varjú C, Bálint Z, Solyom AI, et al. Cross-cultural adaptation of the disabilities of the arm, shoulder, and hand (DASH) questionnaire into Hungarian and investigation of its validity in patients with systemic sclerosis. Clin Exp Rheumatol. 2008;26:776–83.
Penta M, Thonnard JL, Tesio L. ABILHAND: a Rasch-built measure of manual ability. Arch Phys Med Rehabil. 1998;79:1038–42.
Vanthuyne M, Smith V, Arat S, et al. Validation of a manual ability questionnaire in patients with systemic sclerosis. Arthritis Rheum. 2009;61:695–703.
Silman A, Akesson A, Newman J, et al. Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument. J Rheumatol. 1998;25:79–83.
Smyth AE, MacGregor AJ, Mukerjee D, et al. A cross sectional comparison of three self-reported functional indices in scleroderma. Rheumatology. 2003;42:732–8.
Serednicka K, Smyth AE, Black CM, Denton CP. Using a self-reported functional score to assess disease progression in systemic sclerosis. Rheumatology (Oxford). 2007;46:1107–10.
Sandqvist G, Eklund M. Hand mobility in scleroderma (HAMIS) test: the reliability of a novel hand function test. Arthritis Care Res. 2000;13:369–74.
Sandqvist G, Eklund M. Validity of HAMIS: a test of hand mobility in scleroderma. Arthritis Care Res. 2000;13:382–7.
Del Rosso A, Maddali-Bongi S, Sigismondi F, et al. The Italian version of the hand mobility in scleroderma (HAMIS) test: evidence for its validity and reliability. Clin Exp Rheumatol. 2010;28(5 Suppl 62):S42–7.
Ingegnoli F, Boracchi P, Ambrogi F, et al. Hand impairment in systemic sclerosis: association of different hand indices with organ involvement. Scand J Rheumatol. 2010;39:393–7.
Maddali Bongi S, Del Rosso A, Galluccio F, et al. Efficacy of a tailored rehabilitation program for systemic sclerosis. Clin Exp Rheumatol. 2009;27(3 Suppl 54):44–50.
Furst DE, Clements PJ, Hasrris R, et al. Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteine. Ann Rheum Dis. 1979;38:356–61.
Merkel PA, Clements PJ, Reveille JD, et al. Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. J Rheumatol. 2003;30:1630–47.
Torok KS, Baker NA, Lucas M, et al. Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis. Clin Exp Rheumatol. 2010;28(2 Suppl 58):S28–36.
Roberts-Thomson AJ, Massy-Westropp N, Smith MD, et al. The use of the hand anatomic index to assess deformity and impaired function in systemic sclerosis. Rheumatol Int. 2006;26:439–44.
Phumethum V, Jamal S, Johnson SR. Biologic therapy for systemic sclerosis: a systematic review. J Rheumatol. 2011;38:289–96.
Antonioli CM, Bua G, Frigè A, et al. An individualized rehabilitation program in patients with systemic sclerosis may improve quality of life and hand mobility. Clin Rheumatol. 2009;28:159–65.
Mugii N, Hasegawa M, Matsushita T, et al. The efficacy of self-administered stretching for finger joint motion in Japanese patients with systemic sclerosis. J Rheumatol. 2006;33:1586–92.
Schouffoer AA, Ninaber MK, Beaart-van de Voorde LJ, et al. A randomised comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis. Arthritis Care Res (Hoboken). 2011;63:909–17.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Del Rosso, A., Maddali-Bongi, S., Matucci-Cerinic, M. (2014). Hand Function in Scleroderma. In: Duruöz, M. (eds) Hand Function. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9449-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9449-2_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9448-5
Online ISBN: 978-1-4614-9449-2
eBook Packages: MedicineMedicine (R0)